Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 380923, 10 pages
http://dx.doi.org/10.1155/2011/380923
Research Article

Leaf Extracts of Calocedrus formosana (Florin) Induce G2/M Cell Cycle Arrest and Apoptosis in Human Bladder Cancer Cells

1Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
2Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung 40705, Taiwan
3Department of Education and Research, Taichung Veterans General Hospital, Taichung 40705, Taiwan
4Institute of Biomedical Science, National Chung-Hsing University, Taichung 40227, Taiwan
5Department of Forestry, National Chung-Hsing University, Taichung 40227, Taiwan

Received 14 December 2010; Revised 14 March 2011; Accepted 24 March 2011

Copyright © 2011 Sheau-Yun Yuan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Dhawan, A. B. Jeffreys, R. Zheng, J. C. Stewart, and D. W. Knapp, “Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells,” Molecular Cancer Therapeutics, vol. 7, no. 4, pp. 897–904, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. C. C. Peng, K. C. Chen, R. Y. Peng, C. H. Su, and H. M. Hsieh-Li, “Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts,” Cancer Letters, vol. 243, no. 1, pp. 109–119, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. K. Shimada, M. Nakamura, M. A. De Velasco et al., “Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma,” Cancer Science, vol. 101, no. 1, pp. 155–160, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. C. Wilasrusmee, J. Siddiqui, D. Bruch, S. Wilasrusmee, S. Kittur, and D. S. Kittur, “In vitro immunomodulatory effects of herbal products,” American Surgeon, vol. 68, no. 10, pp. 860–864, 2002. View at Google Scholar · View at Scopus
  5. W. J. Craig, “Health-promoting properties of common herbs,” American Journal of Clinical Nutrition, vol. 70, no. 3, pp. 491S–499S, 1999. View at Google Scholar · View at Scopus
  6. D. J. Newman, G. M. Cragg, and K. M. Snader, “Natural products as sources of new drugs over the period 1981-2002,” Journal of Natural Products, vol. 66, no. 7, pp. 1022–1037, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. G. M. Cragg and D. J. Newman, “Plants as a source of anti-cancer agents,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 72–79, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. T. B. Yen, H. T. Chang, C. C. Hsieh, and S. T. Chang, “Antifungal properties of ethanolic extract and its active compounds from Calocedrus macrolepis var. formosana (Florin) heartwood,” Bioresource Technology, vol. 99, no. 11, pp. 4871–4877, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. L. K. Chao, K. F. Hua, H. Y. Hsu, Y. C. Su, and S. T. Chang, “Bioactivity assay of extracts from Calocedrus macrolepis var. formosana bark,” Bioresource Technology, vol. 97, no. 18, pp. 2462–2465, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. K. P. Chao, K. F. Hua, H. Y. Hsu, Y. C. Su, and S. T. Chang, “Anti-inflammatory activity of sugiol, a diterpene isolated from Calocedrus formosana bark,” Planta Medica, vol. 71, no. 4, pp. 300–305, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. C. C. Tsai, C. J. Chen, H. W. Tseng et al., “Cytomic screening of immuno-modulating activity compounds from Calocedrus formosana,” Combinatorial Chemistry and High Throughput Screening, vol. 11, no. 10, pp. 834–842, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. S. Cheng, H. T. Chang, C. L. Wu, and S. T. Chang, “Anti-termitic activities of essential oils from coniferous trees against Coptotermes formosanus,” Bioresource Technology, vol. 98, no. 2, pp. 456–459, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. C. L. Hsieh, M. H. Tseng, Y. Y. Shao et al., “C terpenoids from the bark of Calocedrus macrolepis var. formosana with activity against human cancer cell lines,” Journal of Natural Products, vol. 69, no. 11, pp. 1611–1613, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. D. J. Stravopodis, P. K. Karkoulis, E. G. Konstantakou et al., “Thymidylate synthase inhibition induces p53-dependent and p53-independent apoptotic responses in human urinary bladder cancer cells,” Journal of Cancer Research and Clinical Oncology, vol. 137, pp. 359–374, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. C. C. Peng, K. C. Chen, R. Y. Peng, C. C. Chyau, C. H. Su, and H. M. Hsieh-Li, “Antrodia camphorata extract induces replicative senescence in superficial TCC, and inhibits the absolute migration capability in invasive bladder carcinoma cells,” Journal of Ethnopharmacology, vol. 109, no. 1, pp. 93–103, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. S. Kim, H. S. Lee, S. K. Lee et al., “12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells,” Phytomedicine, vol. 17, pp. 1127–1132, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. J. M. Mulligan, L. M. Greene, S. Cloonan et al., “Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines,” Molecular Pharmacology, vol. 70, no. 1, pp. 60–70, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. S. Haldar, A. Basu, and C. M. Croce, “Bcl2 is the guardian of microtubule integrity,” Cancer Research, vol. 57, no. 2, pp. 229–233, 1997. View at Google Scholar · View at Scopus
  19. J. E. Chipuk and D. R. Green, “Do inducers of apoptosis trigger caspase-independent cell death?” Nature Reviews Molecular Cell Biology, vol. 6, no. 3, pp. 268–275, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. C. Norbury and P. Nurse, “Animal cell cycles and their control,” Annual Review of Biochemistry, vol. 61, pp. 441–470, 1992. View at Google Scholar · View at Scopus
  21. B. C. Dash and W. S. El-Deiry, “Phosphorylation of p21 in G/M promotes cyclin B-Cdc2 kinase activity,” Molecular and Cellular Biology, vol. 25, no. 8, pp. 3364–3387, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. A. Kumagai and W. G. Dunphy, “The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system,” Cell, vol. 64, no. 5, pp. 903–914, 1991. View at Google Scholar · View at Scopus
  23. K. L. King and J. A. Cidlowski, “Cell cycle and apoptosis: common pathways to life and death,” Journal of Cellular Biochemistry, vol. 58, no. 2, pp. 175–180, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. P. M. Checchi, J. H. Nettles, J. Zhou, J. P. Snyder, and H. C. Joshi, “Microtubule-interacting drugs for cancer treatment,” Trends in Pharmacological Sciences, vol. 24, no. 7, pp. 361–365, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Honore, E. Pasquier, and D. Braguer, “Understanding microtubule dynamics for improved cancer therapy,” Cellular and Molecular Life Sciences, vol. 62, no. 24, pp. 3039–3056, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. W. Li, M. S. Lam, A. Birkeland et al., “Cell-based assays for profiling activity and safety properties of cancer drugs,” Journal of Pharmacological and Toxicological Methods, vol. 54, no. 3, pp. 313–319, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. S. Y. Yuan, S. L. Hsu, K. J. Tsai, and C. R. Yang, “Involvement of mitochondrial pathway in Taxol-induced apoptosis of human T24 bladder cancer cells,” Urological Research, vol. 30, no. 5, pp. 282–288, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. Y. H. Kuo, C. H. Chen, S. C. Chien, and H. C. Lin, “Novel diterpenes from the heartwood of Chamaecyparis obtusa var. formosana,” Chemical and Pharmaceutical Bulletin, vol. 52, no. 6, pp. 764–766, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J. P. Liou, C. Y. Wu, H. P. Hsieh et al., “4- And 5-aroylindoles as novel classes of potent antitubulin agents,” Journal of Medicinal Chemistry, vol. 50, no. 18, pp. 4548–4552, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. I. Vitale, A. Antoccia, C. Cenciarelli et al., “Combretastatin CA-4 and combretastatin derivative induce mitotic catastrophe dependent on spindle checkpoint and caspase-3 activation in non-small cell lung cancer cells,” Apoptosis, vol. 12, no. 1, pp. 155–166, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus